Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,254.00    6.00 (0.14%)
Bid:
4,256.00
Ask:
4,260.00
Spread: 4.00 (0.094%)
Market Cap: £4.46b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Director/PDMR Shareholding

25 Mar 2026 15:00

RNS Number : 1273Y
Computacenter PLC
25 March 2026
 

 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

Computacenter plc

(the 'Company')

 

The following notifications are made under Article 19 of the Market Abuse Regulation ('MAR') relating to certain transactions in the shares of the Company by Directors of the Company, Persons Discharging Managerial Responsibilities ('PDMR') of the Company and Persons Closely Associated ('PCA') with the Directors and PDMRs.

 

Grant of Awards - Performance Share Plan ('PSP')

 

The Company announces that on 23 March 2026, in accordance with the rules of the Computacenter Share Plan 2025 (the 'Plan'), the Company granted PSP awards of nil-cost options (the 'PSP Awards') over Ordinary Shares of 75/9 pence each in the capital of the Company ('Ordinary Shares'), to the following Directors/PDMR:

 

Director

Number of shares awarded1

Mr M J Norris (Director)

51,134

Mr K Mortimer (Director)

20,601

1 Calculated using a price of 2919.00 pence per Ordinary Share which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, over the period from 18 March 2026 to 20 March 2026, being the three trading days before the Date of Grant of the PSP Awards.

 

Performance Conditions

No consideration was paid for the grant of the PSP Awards which are structured as a nil cost option, and which shall ordinarily vest and become exercisable by the participants listed above, subject to the satisfaction of the performance conditions set by the Remuneration Committee of the Company which are based on (i) the compound annual growth rate of the Group's adjusted diluted earnings per share ('EPS'), commencing on 1 January 2026 and ending on 31 December 2028 (the 'Performance Period') and (ii) the compound annual growth rate of the Group's Services Revenue over the Performance Period, and (iii) the compound annual EBIT growth rate of the Group's North American business over the Performance Period. The PSP Award is subject to a two-year holding period following vesting. The vested PSP Award held during the holding period will include the right to receive dividend equivalents as shares.

 

PDMR

Number of shares awarded1

Mr S Pereira (PDMR)

2,140

1 Calculated using a price of 2919.00 pence per Ordinary Share which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, over the period from 18 March 2026 to 20 March 2026, being the three trading days before the Date of Grant of the PSP Awards.

 

Performance Condition

No consideration was paid for the grant of the PSP Award which is structured as a nil cost option, and which shall ordinarily vest and become exercisable by the participant listed above, subject to the satisfaction of the performance condition set by the Remuneration Committee of the Company which is based on the compound annual growth rate of the Group's EPS over the Performance Period.

 

All of the PSP Awards set out above will be satisfied out of shares held by the 2011 Computacenter Employee Benefit Trust or by treasury shares held by the Company at the discretion of the Board of the Company. The relevant FCA notifications are set out below.

 

Grant of Awards - Restricted Share Plan ('RSP')

 

The Company announces that on 23 March 2026, in accordance with the rules of the Computacenter Share Plan 2025 (the 'Plan'), the Company granted RSP awards of nil-cost options (the 'RSP Awards') over Ordinary Shares of 75/9 pence each in the capital of the Company ('Ordinary Shares'), to the following Directors/PDMR:

 

Director

Number of shares awarded1

Mr M J Norris (Director)

12,783

Mr K Mortimer (Director)

4,807

 

1 Calculated using a price of 2919.00 pence per Ordinary Share which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, over the period from 18 March 2026 to 20 March 2026, being the three trading days before the Date of Grant of the RSP Awards.

 

Conditions

No consideration was paid for the grant of the RSP Awards which are structured as a nil cost option, and which shall ordinarily vest and become exercisable by the participants listed above, subject to the assessment of performance against a 'good practice' underpin for the period from 1 January 2026 to 31 December 2029 (the "Assessment Period" ) set by the Remuneration Committee of the Company which is based on (i) whether there is a material weakness in the underlying financial health or sustainability of the business over the Assessment Period, (ii) performance against the Company's key strategic priorities being at an appropriate level over the Assessment Period and (iii) whether there has been a materially serious risk and/or reputational event over the Assessment Period. The RSP Awards are subject to a one-year holding period following vesting. The vested RSP Awards held during the holding period will include the right to receive dividend equivalents as shares.

 

PDMR

Number of shares awarded1

Mr S Pereira (PDMR)

1,529

1 Calculated using a price of 2919.00 pence per Ordinary Share which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, over the period from 18 March 2026 to 20 March 2026, being the three trading days before the Date of Grant of the RSP Awards.

 

Conditions

No consideration was paid for the grant of the RSP Award which is structured as a nil cost option, and which shall ordinarily vest and become exercisable by the participant listed above, subject to the assessment of performance against a 'good practice' underpin for the period from 1 January 2026 to 31 December 2028 (the "Assessment Period" ) set by the Remuneration Committee of the Company which is based on (i) whether there is a material weakness in the underlying financial health or sustainability of the business over the Assessment Period and (ii) performance against the Company's key strategic priorities being at an appropriate level over the Assessment Period and (iii) whether there has been a materially serious risk and/or reputational event over the Assessment Period.

 

All of the RSP Awards set out above will be satisfied out of shares held by the 2011 Computacenter Employee Benefit Trust or by treasury shares held by the Company at the discretion of the Board of the Company. The relevant FCA notifications are set out below.

 

Grant of Awards - Deferred Bonus Plan

 

The Company announces that on 23 March 2026, in accordance with the rules of the Computacenter 2017 Deferred Bonus Plan (the 'DBP'), the Company granted conditional awards (the 'DBP Awards') over Ordinary Shares of 75/9 pence each, to the following Directors:

 

Director

Number of shares awarded1

Mr M J Norris (Director)

16,662

Mr K Mortimer (Director)

2,170

1 Calculated using a price of 2919.00 pence per Ordinary Share which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, over the period from 18 March 2026 to 20 March 2026, being the three trading days before the Date of Grant of the DBP Awards.

 

Performance Criteria

The annual performance bonus for the participants listed above are based on performance measures and targets set at the beginning of each financial year. Performance is normally assessed over one financial year. For the bonus paid in respect of 2025, 50 per cent will be paid in cash and 50 per cent, the DBP Award, has been deferred into Ordinary Shares of 75/9 pence each, as detailed above. One-half of the deferred shares from the DBP Award will vest on 24 March 2027 and the remaining deferred shares from the DBP Award will vest on the second anniversary of the Grand Date. Ordinary Shares subject to deferral as part of the DBP Award will include the right to receive dividend equivalents as shares.

 

No consideration was paid for the grant of the DBP Award which is structured as a conditional award, and which shall ordinarily vest for the participants listed above, subject to confirmation by the Remuneration Committee of the Company. The DBP Award set out above, will be satisfied by market purchase of shares. The relevant FCA notifications are set out below.

 

PDMR/PCA FCA Transaction Notification

 

 

1.

 

 

Details of Director/Person Discharging Managerial Responsibilities

 

 

 

 

Name

 

Michael John Norris

 

2.

 

Reason for the notification

 

 

2(a)

 

 

Position/Status

 

Chief Executive Officer

 

2(b)

 

 

Initial Notification/

Amendment

 

 

Initial Notification

 

3.

 

 

Details of the issuer

 

 

3(a)

 

 

Name

 

Computacenter plc

 

3(b)

 

 

LEI

 

549300XSXUZ1I19DB105

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Grant of a nil-cost option PSP award over Ordinary Shares under the Computacenter Share Plan 2025 (the 'PSP Award'). There is no price payable on the grant, vesting or exercise of the PSP Award. Vesting of the PSP Award is subject to the achievement of performance conditions over a three-year period. Any options vested under the PSP Award are subject to a two-year holding period before they can be exercised.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

51,134

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

51,134

 

4(e)

 

 

Date of the transaction

 

 

23-03-2026

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Grant of a nil-cost option RSP award over Ordinary Shares under the Computacenter Share Plan 2025 (the 'RSP Award'). There is no price payable on the grant, vesting or exercise of the RSP Award. Vesting of the RSP Award is subject to the assessment of performance criteria against an underpin over a four-year period. Any options vested under the RSP Award are subject to a one-year holding period before they can be exercised.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

12,783

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

12,783

 

4(e)

 

 

Date of the transaction

 

 

23-03-2026

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

Grant of a conditional award over Ordinary Shares under the Computacenter 2017 Deferred Bonus Plan (the 'DBP Award'). There is no price payable on the grant or vesting of the DBP Award. 

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

16,662

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

16,662

 

4(e)

 

 

Date of the transaction

 

 

23-03-2026

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

 

 

1.

 

 

Details of Director/Person Discharging Managerial Responsibilities

 

 

 

 

Name

 

Keith Mortimer

 

2.

 

Reason for the notification

 

 

2(a)

 

 

Position/Status

 

Chief Financial Officer

 

2(b)

 

 

Initial Notification/

Amendment

 

 

Initial Notification

 

3.

 

 

Details of the issuer

 

 

3(a)

 

 

Name

 

Computacenter plc

 

3(b)

 

 

LEI

 

549300XSXUZ1I19DB105

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Grant of a nil-cost option PSP award over Ordinary Shares under the Computacenter Share Plan 2025 (the 'PSP Award'). There is no price payable on the grant, vesting or exercise of the PSP Award. Vesting of the PSP Award is subject to the achievement of performance conditions over a three-year period. Any options vested under the PSP Award are subject to a two-year holding period before they can be exercised.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

20,601

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

20,601

 

4(e)

 

 

Date of the transaction

 

 

23-03-2026

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Grant of a nil-cost option RSP award over Ordinary Shares under the Computacenter Share Plan 2025 (the 'RSP Award'). There is no price payable on the grant, vesting or exercise of the RSP Award. Vesting of the RSP Award is subject to the assessment of performance criteria against an underpin over a four-year period. Any options vested under the RSP Award are subject to a one-year holding period before they can be exercised.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

4,807

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

4,807

 

4(e)

 

 

Date of the transaction

 

 

23-03-2026

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

Grant of a conditional award over Ordinary Shares under the Computacenter 2017 Deferred Bonus Plan (the 'DBP Award'). There is no price payable on the grant or vesting of the DBP Award. 

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

2,170

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

2,170

 

4(e)

 

 

Date of the transaction

 

 

23-03-2026

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

 

 

 

1.

 

 

Details of Person Discharging Managerial Responsibilities

 

 

 

 

Name

 

Simon John Pereira

 

2.

 

Reason for the notification

 

 

2(a)

 

 

Position/Status

 

Group Company Secretary

 

2(b)

 

 

Initial Notification/

Amendment

 

 

Initial Notification

 

3.

 

 

Details of the issuer

 

 

3(a)

 

 

Name

 

Computacenter plc

 

3(b)

 

 

LEI

 

549300XSXUZ1I19DB105

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Grant of a nil-cost option PSP award over Ordinary Shares under the Computacenter Share Plan 2025 (the 'PSP Award'). There is no price payable on the grant, vesting or exercise of the PSP Award. Vesting of the PSP Award is subject to the achievement of a performance condition over a three year period.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

Nil

 

2,140

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

Nil

 

 

2,140

 

4(e)

 

 

Date of the transaction

 

 

23-03-2026

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Grant of a nil-cost option RSP award over Ordinary Shares under the Computacenter Share Plan 2025 (the 'RSP Award'). There is no price payable on the grant, vesting or exercise of the RSP Award. Vesting of the RSP Award is subject to the assessment of performance criteria against an underpin over a three-year period.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

Nil

 

1,529

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

Nil

 

 

1,529

 

4(e)

 

 

Date of the transaction

 

 

23-03-2026

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

 

Enquiries:

 

Name:

Simon Pereira

Company Secretary

Address:

Computacenter plc

Hatfield Avenue

Hatfield

Hertfordshire

AL10 9TW

Telephone:

+44 (0) 7385 514 715

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEALDSAESKEFA
Date   Source Headline
19th Jan 20184:00 pmRNSDirectorate Change
14th Nov 20177:00 amRNSTrading Statement
27th Oct 20177:00 amRNSTrading Statement 3rd Quarter 2017
18th Oct 20173:46 pmRNSDirector/PDMR Shareholding
15th Sep 201711:30 amRNSDirector/PDMR Shareholding
7th Sep 20171:00 pmRNSHolding(s) in Company
25th Aug 20177:00 amRNSHalf-year Report
8th Aug 20172:30 pmRNSBlock listing Interim Review
5th Jul 201711:30 amRNSDirector/PDMR Shareholding
4th Jul 201711:30 amRNSDirector Declaration
21st Jun 20179:00 amRNSDirector Declaration
7th Jun 20171:30 pmRNSDirector/PDMR Shareholding
4th May 201710:00 amRNSResult of AGM
24th Apr 20177:00 amRNSTrading Statement 1st Quarter 2017
6th Apr 20171:30 pmRNSDirector/PDMR Shareholding
30th Mar 20172:45 pmRNSAnnual Report 2016 & Notice of AGM 2017
30th Mar 20177:00 amRNSDirector Declaration
29th Mar 20175:45 pmRNSDirector/PDMR Shareholding
29th Mar 201712:00 pmRNSDirector/PDMR Shareholding
27th Mar 20175:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20174:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20174:00 pmRNSDirector/PDMR Shareholding
13th Mar 20177:00 amRNSFinal Results 2016
8th Feb 201712:00 pmRNSBlock Listing Interim Review
23rd Jan 20177:00 amRNSPre-Close Trading Statement
10th Jan 20176:00 pmRNSDirector/PDMR Shareholding
14th Dec 20164:30 pmRNSDirector/PDMR Shareholding
1st Dec 20161:00 pmRNSDirector/PDMR Shareholding
28th Nov 20164:15 pmRNSDirector/PDMR Shareholding
28th Nov 20164:15 pmRNSDirector/PDMR Shareholding
17th Nov 201612:00 pmRNSDirector/PDMR Shareholding
15th Nov 201610:00 amRNSDirector/PDMR Shareholding
15th Nov 201610:00 amRNSDirector/PDMR Shareholding
11th Nov 20161:00 pmRNSDirector/PDMR Shareholding
11th Nov 20161:00 pmRNSDirector/PDMR Shareholding
11th Nov 20161:00 pmRNSDirector/PDMR Shareholding
11th Nov 201612:00 pmRNSDirectorate Change
10th Nov 201610:00 amRNSDirector/PDMR Shareholding
9th Nov 20166:00 pmRNSDirector/PDMR Shareholding
9th Nov 20166:00 pmRNSDirector/PDMR Shareholding
21st Oct 20167:00 amRNSQ3 2016 Trading Statement
20th Oct 201611:41 amRNSDirector/PDMR Shareholding
19th Oct 20164:30 pmRNSHolding(s) in Company
19th Oct 20164:30 pmRNSHolding(s) in Company
30th Sep 20165:23 pmRNSHolding(s) in Company
14th Sep 20165:59 pmRNSCompany Secretary Change
9th Sep 20163:00 pmRNSHolding(s) in Company
1st Sep 201610:30 amRNSDirector/PDMR Shareholding
26th Aug 20167:00 amRNSHalf-year Report
8th Aug 20162:00 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.